Linifanib in Treating Patients With Advanced, Refractory Colorectal Cancer
Ontology highlight
ABSTRACT: This phase II trial studies how well Linifanib works in treating patients with advanced, refractory colorectal cancer expressing k-Ras mutations. Linifanib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
DISEASE(S): Stage Ivb Colon Cancer,Recurrent Colon Cancer,Rectal Neoplasms,Stage Iva Rectal Cancer,Stage Ivb Rectal Cancer,Recurrent Rectal Cancer,Stage Iva Colon Cancer,Colonic Neoplasms
PROVIDER: 2107600 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA